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Abstract 24 
 25 
The influence of commercial prebiotics (fructo-oligosaccharides and inulin) and sugars 26 
(glucose and sucrose) on enhancing equol production from soymilk isoflavones by 27 
Bifidobacterium longum BB536 and Bifidobacterium breve ATCC 15700 was evaluated 28 
in vitro.  Sterilized soymilk was inoculated with each bacterial species at 37° C for 48 h. 29 
The growth and β-glucosidase enzyme activity for the two Bifidobacterium species in 30 
soymilk throughout fermentation were assessed. The highest viable count for B. breve 31 
(8.75 log CFU/ml) was reached at 36 h and for B. longum (8.55 log CFU/ml) at 24 h. 32 
Both bacterial species displayed β-glucosidase activity. B. breve showed increased 33 
enzyme activity (4.126 U) at 36 h, while B. longum exhibited maximum activity (3.935 34 
U) at 24 h of fermentation. Among the prebiotics screened for their effect in isoflavones 35 
transformation to equol, inulin delivered the highest effect on equol production. The co-36 
culture of B. longum BB536 and B. breve ATCC15700 in soymilk supplemented with 37 
inulin produced the highest level (11.49 mmol/l) of equol at 48 h of fermentation process. 38 
Level of daidzin declined whereas that of daidzein increased, and then gradually 39 
decreased due to formation of equol when soymilk was fermented using bifidobacterial. 40 
This suggests that the nutritional value of soymilk may be increased by increasing 41 
bioavailability of the bioactive ingredients. Collectively these data identify probiotics and 42 
prebiotic combinations suitable for inclusion in soymilk to enhance equol production. 43 
  44 
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1. Introduction  50 
 51 
A significant body of research has been directed to the nutritious and healthy properties 52 
of soybean and soy products. It has been found that soybean isoflavones and isoflavone-53 
derived metabolites resemble estrogen and exhibit certain of its health benefits (Chen et 54 
al., 2018; Wee et al., 2017; Bilal et al., 2014). Isoflavones include aglycones and their 55 
glycosides (Hughes et al., 2003). It is important to clarify that aglycones (daidzein and 56 
genistein) are the more biologically active form of isoflavones than their glycosides 57 
(genistin, daidzin) (Elghali et al., 2012; Kawakami et al., 2005). Daidzein [7‐hydroxy‐3‐ 58 
(4‐hydroxyphenyl)‐4H‐chromen‐4‐one] is one of the therapeutically important natural 59 
isoflavones originated in soybean. Daidzein has been approved for relieving menopausal 60 
syndromes in females, treatments of hypertension, coronary heart disease, cerebral 61 
clotting, dizziness, and deafness. However, daidzein does not commonly show the 62 
estrogenic activity unless it is converted to equol by the intestinal bacteria (Wang et al., 63 
2017). Equol (4', 7-isoflavandiol) is an isoflavone metabolite derived from 64 
daidzin/daidzein by certain bacterial biotypes in small intestine and colon of human, has 65 
non-planar construction which offers its physiological properties (Raffi, 2015; Del Rio et 66 
al., 2013; Setchell and Clerici 2010). It is more stable, more easily absorbed, and has 67 
stronger estrogenic activity than the other isoflavones or its precursor molecule daidzein 68 
(Jackson et al., 2011; Setchell et al., 2005). 69 
In addition, equol has been confirmed as having a protective action on osteoporosis by up 70 
regulating the minerals content and bones density in menopausal women (Lambert et al., 71 
2017). (S)‐Equol exhibits potential neuroprotective effects when it was used by 72 
Alzheimer's patients (Wilkins et al., 2017). About 25–30% of younger individuals are 73 
4 
 
able to produce equol in vivo when fed with soy bean products. Thus, there is a need to 74 
improve the methods used for equol production. One of promising equol production 75 
approaches is natural bacterial fermentation. However, lower growth and productivity are 76 
the major problems of this procedure which should be resolved (Li, 2019). 77 
Bifidobacterium species are reported to exhibit health-promoting effects and are 78 
classified as probiotic organisms since they are thought to enhance the bacterial 79 
homeostasis in the human digestive tract (Schrezenmeir and de Vrese, 2001). Probiotics 80 
possess several healthy features, including antimicrobial and anticarcinogenic activities 81 
as well as other valuable health effects to the host (Lourens-Hattingh and Viljoen, 2001). 82 
Soymilk helps on delivering probiotic to the consumer (Otienoet al., 2005). Moreover, 83 
studies reported that, soymilk is a good culture medium for bifidobacterial growth. This 84 
is for the reason that it consists of various carbohydrates, sucrose, raffinose, glucose and 85 
stachyose which are fermented by the majority of strains affiliated to this genus (Liu, 86 
1997; Desjardins et al., 1990). However, humans are not able to produce sufficient 87 
amounts of α-galactosidase, (an enzyme that catalyzes breakdown of the terminal α-88 
galactosyl moieties of polysaccharides and oligosaccharides, in the digestive system to 89 
completely digest the galactosaccharides of soymilk. Therefore, bacterial metabolism of 90 
these α-galactosyl oligosaccharides requires strains with higher α-galactosidase 91 
activity(Lu-Kwang et al., 2018; Sengupta et al., 2015). 92 
A prebiotic is identified as “a substrate that is selectively utilized by host microorganisms 93 
conferring a health benefit. This definition expands the idea of prebiotics to possibly 94 
include non-carbohydrate substances, applications to body sites other than the 95 
gastrointestinal tract, and diverse categories other than food (Gibson et al., 2017). Since 96 
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the major influence of prebiotics is to stimulate bacterial growth and/or activity, primarily 97 
Bifidobacteria have a role in promoting human health condition (Park et al., 2016; Kaur 98 
and Gupta 2002; Gibson, 1995). Besides, prebiotics (FOS and inulin) are recognized to 99 
have influence on development of Lactobacillus and/or Bifidobacterium spp. Therefore, 100 
supplementation of soymilk with prebiotic could enhance bacterial growth in soymilk by 101 
offering additional supply of oligosaccharides. Furthermore, fructo-oligosaccharides 102 
(FOS), inulin and galacto-oligosaccharides (GOS) have attracted wide attention because 103 
they are appropriate food for Bifidobacteria in the intestine and can enhance the stability 104 
of useful bacteria in the gut, therefore they can improve human's health (Simpson and 105 
Campbell, 2015; Huebner et al., 2007; Tuohy et al., 2003). A study by Roberfroid et al., 106 
(1998) stated that the inulin-type fructans are the only prebiotics characterized as 107 
functional food ingredients; however another one reported that prebiotics with specific 108 
standard (in in vivo and in vitro experiments) effective features include inulin, fructo-109 
oligosaccharides (FOS) and galacto-oligo-saccharides (GOS) (Florowska et al., 2016). 110 
In the present study, soymilk was used as a natural source of isoflavones, so it is better to 111 
explain that, selection of bacterial species for screening of equol production from soymilk 112 
was created depending on β-glucosidase activity of bacterial species. Due to our interest 113 
in β-glucosidase enzyme, this study only included screening of the β-glucosidase activity 114 
as it is essential for enzymatic transformation of isoflavone glycosides to aglycones to 115 
provide excessive levels of daidzein, the direct precursor of equol (Yuksekdag et 116 
al.,2017; Otienoet al., 2006; Tsangalis et al., 2002). Also this study evaluated (in-vitro) 117 
the influence of two commercial prebiotics (fructo-oligosaccharides and inulin) and two 118 
6 
 
sugars (glucose and sucrose) on equol production from soymilk isoflavones by 119 
Bifidobacterium longum BB536 and Bifidobacterium breve ATCC15700. 120 
 121 
2. Materials and Methods 122 
2.1 Materials  123 
All standards (daidzein, equol and daidzin) were bought from Millipore Sigma Chemical 124 
Co. (St. Louis, USA). Soybean (Glycine max (L.) Merrill) was bought from the local 125 
market in Serdang-Selangor, Malaysia. The chemicals of analytical HPLC grade were 126 
purchased from Merck (Darmstadt, Germany). Brain Heart Infusion (BHI) broth was 127 
used for motivation of bacterial strains. It was handled in compliance with the 128 
manufacturing ´instructions (Oxoid Ltd., West Heidelberg/Vic., Australia). Glucose as 129 
well as Sucrose was from Millipore Sigma (Louis, USA), while Inulin and Fructo-130 
oligosaccharides from Orafti Pty.Ltd,(Tienen, Belgium). 131 
 132 
2.2 Methods 133 
2.2.1Bifidobacteria culture conditions 134 
Unadulterated cultures of B. breve ATCC 15700and B. longum BB536 were used. Gram 135 
staining was used to check the purity of bacterial cultures. The standard bacterial culture 136 
was proliferated and stored in 40% glycerol at −80°C for further use. Bifidobacteria grow 137 
anaerobically. Anaerobic environment was obtained with AnaeroGen sachets (Oxoid 138 
Ltd., West Heidelberg/Vic., Australia). 139 
 140 
2.2.2 Production of soymilk  141 
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Soymilk was produced following the procedure described by Hou et al. (2000) with few 142 
changes. Soybean grains were firstly cleaned up and soaked overnight in distilled water. 143 
The soaked soybeans were added to ten times the weight of (100 g dry soya bean to 1000 144 
ml water) distilled water and boiled for 30 min at 95°C in a water bath. Further it was 145 
blended for 5 min. The obtained slurry was then purified through double-layered 146 
cheesecloth to yield soymilk (New England Cheese making supply company, South 147 
Deerfield, MA, USA). Soymilk was autoclaved at 121°C for 15 min and stored in a 148 
refrigerator (4°C). 149 
2.2.3 Enumeration of bacterial population 150 
Viable cell counts of B. breve and B. longum were established in duplicate using the pour 151 
plate method on BHI agar medium. Each fermented soymilk was added to 90 ml sterile 152 
0.85% saline (w/v) and vortexed for 30 sec. Resultant suspension was serially diluted 153 
with sterile 9ml saline and 1 ml of the proper dilution was used for selective enumeration 154 
by the pour plate technique. The cell growth of each organism was assessed by 155 
enumerating a bacterial population on BHI agar at 0, 12, 24, 36 and 48 h of fermentation. 156 
To be effective, plates containing 30–300 colonies were counted and recorded as CFU 157 
per ml of fermented soymilk. 158 
2.2.4Preparation of bacterial single and co- culture inoculums 159 
Bacterial species (B. breve ATCC 15700, B. longum BB536) were activated in BHI 160 
medium by relocating three times in 10 ml of BHI broth and incubation at 37 ºC 20 h 161 
followed by collecting bacterial cells by centrifuging (3000 × g for 15 min). To get 162 
bacterial co-culture cell suspensions, the two cell suspensions were mixed at a volume 163 
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ratio of 1:1. Inoculums of the bacterial single and co-culture were set by using 100 ml of 164 
sterile soymilk and incubation for 20 h at 37 ºC. 165 
2.2.5β-Glucosidase activity assay 166 
B. longum BB536 and B. breve ATCC15700 were activated by incubating in 10 ml of 167 
BHI broth. Incubation was carried out at 37°C for 20 h. Bacterial cells were collected by 168 
centrifugation at 3000 × g for 15 min. The inoculum of single culture for every 169 
bacteriological strain was made with 50 ml of sterile soymilk and incubation for 20 h at 170 
37°C. Ten milliliters of the vigorous culture were injected into 250 ml of each soymilk 171 
(5% v/v) batches of and incubated for 48 h at 37 °C. Fifty milliliters were withdrawn 172 
aseptically from every inoculum at 12, 24, 36 and 48 h of incubation to measure the 173 
enzyme activity. β-Glucosidase activity of the bacterial strains was evaluated by 174 
identifying the degree of hydrolysis of the substrate ρ-NPG. It was prepared in 100 mM 175 
sodium phosphate buffer (pH 7.0) (Millipore Sigma, Chemical Co., St. Louis, Mo- 176 
U.S.A). One milliliter of ρ NPG (5 mM) was added to 10 ml of each aliquot and 177 
incubated at 37°C for 30 min (Otieno et al., 2006; Scalabrini et al., 1998). The reaction 178 
was ended by adding of 500 μl from 1 M cold sodium carbonate. The aliquot was 179 
transferred to centrifuge tube followed by centrifugation (14,000 g for 30 min) using 180 
Eppendorf refrigerated centrifuge (Model 5810 R). The quantity of ρ-nitro-phenol 181 
relieved was determined by Perkin Elmer spectrophotometer (Model: Lambda 25 182 
UV/VIS Spectrophotometer) at 420 nm. One unit of the enzyme was defined as the 183 
amount of enzyme that released1 μ mol of ρ-nitro-phenol from the substrate ρ NPG, per 184 
ml per min under assay conditions. 185 
2.2.6 Batch fermentation conditions 186 
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 The fermentation process was executed in 1 litre volume bioreactor BIOSTAT QDCU3 187 
(Sartorius BBI System GmbH, Melsungen, Germany) and controlling of temperature was 188 
achieved using water bath (Jeio Tech Desk Top, Seoul, South Korea) and an electronic 189 
stirrer (Gas-Col Ltd, Northvale, NJ 07647, USA). The temperature was set at 37°C. 190 
Anaerobic condition for fermentation was conserved by flushing oxygen-free nitrogen 191 
gas through the medium. No control stood for pH. The stirring speed for all batch 192 
fermentation was set at 200 rpm/min. One hundred ml inoculums of single culture for 193 
each bacterial strain (B. longum BB536 and B. breve ATCC 15700) in sterile soymilk 194 
were transferred to the fermenter to inoculate the soymilk in a 2-L vessel (with 1 L 195 
working volume). Samples of fermented soymilk were taken at 0, 24 and 48 h into sterile 196 
universal bottles to examine changes on isoflavones concentrations. 197 
2.2.7 Sample preparation for isoflavones investigation by high performance liquid 198 
chromatography (HPLC) 199 
Fermented soymilk (2 ml) was added to 80% methanol (8 ml) and stirred for 2 h at 25°C. 200 
Then, the blend was centrifuged at 9000 rpm for 20 min. The supernatant was clarified 201 
using a 0.22 μm syringe membrane into HPLC vials and kept at -20°C for HPLC 202 
investigation. 203 
2.2.8 High Performance Liquid Chromatography (HPLC) protocol 204 
HPLC protocol was in accordance with the method mentioned by Elghali et al., (2012) 205 
with some alterations. Twenty microliters of sample were injected into high-performance 206 
liquid chromatography (HPLC) (Model CO-2065 JASCO Corporation Hachioji, Tokyo, 207 
Japan) equipped with C18 reversed-phase column (25 cm × 4.5 cm × 5 ) (Ascentis–208 
Supelco, Sigma-Aldrich Co. LLC. L, USA), diode array ultraviolet (UV) visible detector, 209 
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vacuum degasser, and thermostatically controlled column compartment. Column 210 
temperature was set at 27°C. HPLC gradient elution was composed of 10% acetonitrile 211 
solution in water (solution A) and 90% acetonitrile solution in water (solution B). The 212 
elution program was as follows: solution B was run at 30% for 15 min, linearly increased 213 
to 50% for 10 min, and then linearly increased to 70% for 5 min. The flow rate was at 1 214 
ml/min. A diode array UV-visible detector was set at 270 nm. UV spectra and retention 215 
times of the metabolites produced from daidzin and daidzein by bacteria were compared 216 
with those of the standard compounds daidzin, daidzein and equol in HPLC 217 
chromatograms. 218 
2.2.9 Screening of prebiotics for equol production 219 
Commercial sugars and prebiotics were screened for ability to enhance equol production 220 
from fermented soymilk. They were: glucose (≥99.5%) and sucrose (≥99.5%) purity 221 
[Sigma, Louis, USA], inulin and fructo-oligosaccharides (OraftiPty. Ltd, Tienen, 222 
Belgium). The inulin used was Raftiline ST with a purity of 92% and an average degree 223 
of polymerization (DP) of 10. The fructo-oligosaccharide (FOS) which utilized was 224 
Raftilose P95 that formed from 5% of glucose, fructose and sucrose. It also composed of 225 
oligo-fructose with DP ranging from 2-7 with an average of 4. One hundred ml of sterile 226 
soymilk supplemented with Inulin, FOS, Glucose and Sucrose (1%w/v) individually was 227 
inoculated with activated culture of (B. breve ATCC15700 and B. longum BB536) and 228 
incubated anaerobically at 37°C for 48 h. The soymilk medium was set to contain a final 229 
concentration 1% (w/v). Trials of inoculated soymilk were taken at 12, 24, 36 and 48 h to 230 
measure the quantity of isoflavones by the usage of HPLC (see section 2.2.8). 231 
3. Statistical analysis 232 
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Results analysis was performed using SPSS version 16. Data achieved were subjected to  233 
analysis of variance (ANOVA) and minimum significant difference tests (LSD). Fisher 234 
test was used to classify the significant differences among mean values (P≤ 0.05). 235 
4. Results and Discussion 236 
4.1Cell growth during fermentation 237 
Growth of B. breve and B. longum in soymilk during fermentation was assayed by 238 
enumerating the viable cell counts. Table (1) shows the growth pattern of B. breve and B. 239 
longum at 0, 12, 24 and 48 h in soymilk during fermentation at 37°C. The highest viable 240 
counts for B. breve (8.75log CFU/ml)and B. longum (8.55 log CFU/ml) was reached at 36 241 
and 24 h, respectively. These findings agreed with those showed that different lactic acid 242 
bacteria strains revealed greater (7–9 log CFU/ml) cell population in soymilk (Rekha, 243 
&Vijayalakshmi, 2011; Chun et al., 2007). Moreover, after 48 h there was dropping on  244 
B. breve and B. longum growth, which clarified the conversion from exponential to 245 
stationary growth phase. The diminution in population was 2.47 and 2.37 log CFU/ml, 246 
respectively, over 48 h of incubation. Reduction in the growth of bifidobacteria at 48 h 247 
fermentation is probably owing to shortage of nutrient supply in the medium, which is 248 
strongly supported by Rekha, &Vijayalakshmi, (2011) and Scalabarini et al. (1998), who 249 
found that the nutrient content of soymilk is reduced at 48 h fermentation with 250 
Bifidobacteria, fully to one-half of the original concentration. Donkar and Shah (2008) 251 
stated that the maximum viable count took place at 12 h for L. casei L26, 24 h for B. 252 
lactis B94, and 36 h for L. aciophilus L10. However, the cell growth in soymilk 253 
fermentation is influenced by the cultures and fermentation period (Jiyeon et al., 2008).  254 
4.2β-Glucosidase activity of Bifidobacterium species in fermented soymilk 255 
  256 
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β-Glucosidase activity of soymilk fermented with Bifidobacterium species is shown in 257 
Table 2. Both bacterial species exhibited measurable levels of the enzyme activity. The 258 
enzyme activity differed between the tested organisms. Moreover, there was a significant 259 
difference (P≤ 0.005) in β-glucosidase activity at the duration of 48 h for the fermented 260 
soymilk. However, the maximum enzyme activity for B. breve (4.126 U) and B. longum 261 
(3.935 U) was achieved at 36 and 24 h of fermentation, respectively. This is similar to the 262 
findings reported by Rekha, &Vijayalakshmi, (2011) and Otieno et al., (2005) who 263 
mentioned that probiotic bacteria (Bifidobacterium and Lactobacillus) are known to 264 
display strain-dependent β-glucosidase activity in soymilk. However, relied upon β-265 
glucosidase activity in soymilk, it seemed that L. acidophilus and L. casei strains 266 
presented superior β-glucosidase activity (2.204; 2.199 U), respectively,  to that of B. 267 
animalis BB12 (2.095 U), B. longum 20099 (1.998U) and B. longum 536 (1.972U) 268 
(Otieno et al., 2005). Mostly; β-glucosidase activity was established to be reliant on time 269 
and strain. It is notices that, soymilk fermented with B. breve, which had the maximum β-270 
glucosidase activity (4.126 U) at 36 h of fermentation, represented the highest cell 271 
number (8.75 log CFU/ml) also at 36 h. Similarly, soymilk fermented with B. longum 272 
which has the highest β-glucosidase activity (3.935 U) at 24 h of fermentation, had a 273 
maximum cell number (8.55 log CFU/ml) at 24 h of fermentation. Therefore, increased 274 
cell growth may be followed by an increase in enzyme activity. It appears that there is a 275 
correlation between β-glucosidase activity and growth characteristics during fermentation 276 
of soymilk. So, the decrease in β-glucosidase activity at 48 h might be due to decline of 277 
the bacterial growth at 48 h of fermentation time (Table 1). These findings agreed with 278 
those of Donkar and Shah (2008) who stated that there is a parallel relationship between 279 
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growth of microorganisms in soymilk and β-glucosidase activity. Otieno et al., (2005) 280 
stated that, the increase in β-glucosidase activity and the subsequent decline apparently 281 
corresponded to the growth of these probiotic microorganisms in the soy media (growth 282 
results not shown). However, the tested bacterial strains revealed an increase in β-283 
glucosidase activity upon incubation time of up to 24 h followed by reduction as 284 
fermentation progressed. Three strains of L. acidophilus and two strains of L. casei 285 
exhibited increasing β-glucosidase activity up to 24 h and declining as fermentation 286 
proceeded. According to the result achieved from this research which was intended for 287 
the screening of β-glucosidase enzyme activity of different bacterial species, B. breve 288 
ATCC 15700 and B. longum BB536 exhibited different β-glucosidase activity through 289 
incubation in soymilk for 48 h. Accordingly, β-glucosidase activity is strain reliant and 290 
differs amongst the organisms. In addition, Donkor and Shah (2008)reported that, L. 291 
acidophilus L10, displayed higher β-glucosidase activity, when comparing to B. lactis 292 
B94 and L.casei L26. Moreover, another study found that Lactobacillus acidophilus 293 
exhibited the highest β-glucosidase activity at 24 h of fermentation in soymilk compared 294 
to Bifidobacterium spp. and L. casei (Otieno et al., 2006).Furthermore, Bifidobacteria 295 
species showed different levels of β-glucosidase yields dependent on the sugar quantity 296 
for the cultivation media required by the species and to the phase of growth (Tsangalis et 297 
al., 2002). 298 
4.2 Concentrations of isoflavones in plain soymilk fermented with two bacterial species 299 
As presented in Table 3, the amounts of isoflavones isomers are not significantly changed 300 
and equol was not found in plain soymilk.  301 
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Moreover, the level of isoflavones glucosides (daidzin) was significantly declined when 302 
soymilk fermented with B. breve. The levels of daidzin at 0, 24 and 48 h were 303 
10.36±0.02, 8.45±0.03 and 7.38±0.01 mmol/l , respectively. Instead, the concentrations 304 
of daidzein increased significantly through fermentation of soymilk with B. breve. 305 
However, at 0 h, the concentration of daidzein was 1.48±0.02 and after 12 h of incubation 306 
it was 6.61 ±0.02 mmol/l , then it was followed by gradually decrease in the 307 
concentrations due to production of equol. Moreover, at 0 h, equol was not detected, after 308 
12 h it was 0.56±0.04 and then increased regularly to2.23±0.04mmol/l  after 48 h of 309 
incubation time. Furthermore, once soymilk was fermented with B. longum, the 310 
concentrations of daidzin were decreased significantly from 10.35 mmol/l at 0 h to 7.15 311 
mmol/l after 48 h of incubation period. In contrast daidzein concentrations were 312 
increased from 1.47 at 0 h to 7.34 mmol/l after 24 h. Later, it started to decrease slowly 313 
after 36 h owing to equol production. 314 
 315 
4.3 Effect of prebiotics on equol production 316 
 317 
In the current research the effects of the selected prebiotics such as (inulin, FOS) and 318 
glucose and sucrose on equol production from soymilk isoflavones using different 319 
bacterial species (B.longumBB536 and B. breve ATCC 15700) were estimated. Table (3) 320 
shows the results of plain soymilk fermentation with B. longum BB536 and B. breve 321 
ATCC 15700. There was noticeable decrease in isoflavone glycoside (daidzin) and   322 
daidzein parallel to increasing of equol production by fermentation time. 323 
Table 4 represents the influence of adding sucrose to soymilk on equol production. As 324 
shown, by 48 h of incubation, B. longum BB536 and B. breve ATCC 15700 co-culture 325 
delivered high quantity of equol (7.31 mmol/l); this amount is high compared to that 326 
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being produced in the case of plain soymilk. These findings go along with those 327 
demonstrated by Wei et al. (2007), which revealed that supplementation of soymilk with 328 
sucrose for isoflavones aglycones and equol production using five strains of isoflavones 329 
metabolizing microorganism, yielded smaller quantities of aglycones and equol than 330 
those observed when soymilk was enriched with fructose and lactose sugars. Results for 331 
the effect of glucose addition on soymilk fermented with single and co-culture of B. 332 
breve ATCC 15700 and B. longum BB536 for 48 h were also displayed in Table 4. The 333 
results showing that, there is no significant different in the amounts of daidzin, daidzein 334 
and equol in soymilk supplemented by glucose compare to those of the plain soymilk 335 
during the fermentation time. This finding is consistent with that of Tsangalis et al. 336 
(2002) who stated that, the concentrations of daidzin; daidzein and equol after 48 h 337 
incubation of 4 strains of Bifidobacterium in soymilk supplemented with glucose were 338 
approximately the same in complemented soymilk and in ordinary soymilk by 24 h of 339 
fermentation.  The effect of supplementation of soymilk by FOS on equol production is 340 
varying within the Bifidobacteria species (Table 5). B. breve ATCC 15700 showed high 341 
amount (4.94 mmol/l) of equol after 48 h incubation period comparing to plain soymilk. 342 
Co-culture from B. breve ATCC 15700 and B. longum BB536 showed high level (8.63 343 
mmol/l) of equol after 48 h incubation period. These findings remained parallel to those 344 
published by Uehara et al. (2001), who disclosed that the growth of bifidobacteria and 345 
furthermore the transformation of isoflavone conjugate to produce the correspondence 346 
aglycones and equol can be stimulated by FOS. The present results also agree with the 347 
finding that addition of FOS to soymilk professionally and significantly (P ≤ 0.05) 348 
increases the β-glucosidase activity, and this was dominant in soymilk fermented with L. 349 
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acidophilus (Yeo & Liong 2010) and with Ohta et al., (2002) who reported FOS 350 
enhanced cecal β-glucosidase action and daidzein conversion to equol in both OVX and 351 
SH mice. Consequently, these finding viewed that, FOS increased the growth of bacteria 352 
species responsible for the transformation, β-glucosidase activity and subsequently the 353 
bioavailability of isoflavones. Alternatively, Decroos et al. (2005) and Zafar et al. (2004) 354 
established that addition of fructo-oligosaccharides to the food could be a reason for 355 
equol production inhibition. As the digestion of FOS by gastrointestinal bacteria result in 356 
a great relief of hydrogen, the incidence of FOS possibly will change the colonic 357 
Microbiota and destroy the bacteria accountable for equol production and at the same 358 
time initiates alteration in hydrogen utilization; therefore, daidzein may not be 359 
metabolized to dihydrodaidzein or equol. The present results indicate that, addition of 360 
FOS and sucrose to soymilk significantly (P≤0.05) increases equol production from 361 
daidzein in fermented soymilk. Instead, Tsuji et al. (2010) confirmed that the addition of 362 
FOS or sucrose to soymilk significantly inhibited equol production by the human isolated 363 
bacterium Slackia sp. Strain NATTS. The results demonstrating the influence of inulin in 364 
transformation of isoflavones to produce equol are shown in table (5). It was noticed 365 
addition of inulin to soymilk offered the highest (co-culture =11.49 mmol/l) amount of 366 
equol among both single and co-culture comparing to other carbohydrates added to 367 
soymilk. However, these findings are differing from those established by Zafar et al. 368 
(2004), who published that the absorption and concentrations of plasma equol were 369 
affected negatively by inulin. Levels of equol in serum were significantly lesser in the 370 
group nourished in inulin relative to that nourished in inulin free isoflavones diets. 371 
Another study revealed that inulin exhibited the greatest impact in hydrolyzing the 372 
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malonyl daidzin, and this was most dominant in soymilk fermented by Bifidobacterium 373 
FTDC 8943 (P < 0.05).  Addition of inulin to soymilk is significantly (P < 0.05) reduced 374 
the level of malonyl daidzin in soymilk fermented with Bifidobacterium FTDC 8943 375 
about 49.3 % (Yeo and Liong 2010). Moreover, a study was described that ingestion of 376 
soy isoflavones with inulin for 21 days result on increases of plasma daidzein 377 
concentration in postmenopausal women compared with intake of intake of soy 378 
isoflavones without inulin (Zafar et al., 2004). This indicated that inulin has an influence 379 
on transformation of isoflavones glucosides via enhancing the growth of the colonic 380 
bacteria and therefore increasing the amount and activity of the bacterial enzymes 381 
responsible for isoflavones metabolism in the gut and besides increases their absorption 382 
and bioavailability (Piazza et al., 2007). Yet, these results agreed with our finding which 383 
showed that the high rate of conversion of daidzin to daidzein when inulin was added to 384 
soymilk medium during the fermentation process which made daidzein (the primary 385 
precursor of equol) more available. Table 6 summarizes the results for equol produced in 386 
fermented soymilk.  The amount of equol produced by single culture (B. breve ATCC 387 
15700 / B. longum BB536) was less than that produced when fermentation was carried 388 
out with the co-culture of B. breve ATCC 15700 and B. longum BB536.The co-culture 389 
promotes high rates of β-glucosidase hydrolysis to aglycones than a single bacterial 390 
culture. Also it may offer nutrients and circumstances that someway preserve the 391 
sustainability of the other bacteria in the mixture of cultures (Garro et al., 2004). 392 
5. Conclusion 393 
 394 
Estimation of β-glucosidase activity for bacterial species found that, both bacterial 395 
species tested can generate different levels of β-glucosidase activity according to 396 
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fermentation time. However, B. breveATCC15700 exhibited maximal β-glucosidase 397 
activity at 36 h, while B. longum BB536 got it by 24 h of fermentation period (48 h) in 398 
soymilk. Therefore, the hydrolytic ability and enzyme activity could be unique for each 399 
strain. These results enhance our understanding of the impact of prebiotics on equol 400 
production from soymilk isoflavones. However, the results established that, all tested 401 
prebiotics had significant effect in equol production, but inulin exhibited the highest level 402 
of equol production comparing to FOS. So it was recommended that, in order to gain 403 
high levels of equol from soymilk isoflavones it is better to use bacterial co- culture and 404 
enrich soymilk with inulin. 405 
 406 
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 585 
 586 
Table 1: Growth of B. breve ATCC15700 and B. longum BB536 during fermentation 587 
of soymilk for 48h at 37°C 588 
Time/ h log CFU/ml 
 
B. breve B.  longum 
0 4.60±0.03a 4.61±0.01a 
12 6.58±0.02b 6.45±0.04b 
24 7.50±0.01c 8.55±0.02c 
36 8.75±0.02d 7.35±0.01d 
48 6.28±0.01b 6.18± 0.02b 
Values are means of log CFU/ml in soymilk during the fermentation time ± standard 589 
deviation. Means in the same column with different superscripts letters are significantly 590 
different (P ≤ 0.05). 591 
 592 
 593 
 594 
 595 
 596 
Table 2: β-Glucosidase activity of B. breve ATCC 15700 and B. longum BB536 in 597 
soymilk fermented for 48 h at 37°C. 598 
 599 
Incubation time (h) B. breve B. longum 
   
12 2.208±0.20a 2.683±0.24a 
24 3.365±0.19b 3.935±0.79b 
36 4.126±0.33c 3.186±0.05b 
48 2.314±0.39a 2.015±0.03c 
 600 
Values were means ± standard deviation (SD) of units of enzymes (n = 7).a–c Means in 601 
the same column with different superscripts are significantly different (P≤0.05). One unit 602 
of enzyme (U) is the amount of β-glucosidase that released one µ molar of ρ-nitrophenol 603 
from ρ-NPG per ml/min at 37°C. 604 
 605 
 606 
 607 
 608 
 609 
 610 
 611 
 612 
 613 
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Table 3: Concentrations of isoflavones isomers (mmol l-1) in plain soymilk 614 
fermented by two bacterial species at 0, 12, 24, 36 and 48 h of incubation at 37 °C. 615  616 
Values are Means of concentrations of isoflavones in soymilk during the fermentation 617 
period± standard deviation. Means in the same column with different superscripts letters 618 
are significantly different (P ≤ 0.05). Values < 0.01 are considered to be not detected 619 
(ND). 620 
 621 
 622 
 623 
 624 
 625 
 626 
 627 
 628 
 629 
 630 
 631 
 632 
 633 
 634 
 635 
 636 
 637 
 638 
 639 
 640 
 641 
Treatment Time(h)  Isoflavones isomers  
  Daidzin Daidzein Equol 
Soymilk- 0 10.36±0.11a 1.48±0.03a ND 
(control) 12 10.38±0.05a 1.46±0.06a ND 
 24 10.35±0.03a 1.48±0.04a ND 
 36 10.37±0.03
a 1.49±0.10a ND 
 48 10.38±0.02a 1.47±0.04
a ND 
B. breve 0 10.36±0.02a 1. 48±0.02a ND 
 12 9.34±0.02b 6. 61±0.02b 0.56±0.01a 
 24 8.45±0.03c 5.94±0.02b 1.38±0.01b 
 36 7.58±0.03d 4.11±0.03c 1.74±0.02b 
 48 7.38±0.01d 3.02±0.01d 2.23±0.04c 
B. longum 0 10.35±0.0a 1.47±0.04a ND 
 12 9.45±0.05
b 4.63±0.05b 0.22±0.01a 
 24 8.46±0.05b 7.34±0.01c 0.89±0.05b 
 36 7.48±0.07c 6.23±0.04d 1.88±0.06c 
 48 7.15±0.01c 5.18±0.02f 2.01±0.03c 
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Table 4: Concentration of isoflavones (mmol l-1) in soymilk supplemented with 642 
Sucrose and Glucose and fermented with single and co-culture of B. breve and B. 643 
longum BB536for 48 h 37⁰C. 644 
Values are Means of concentrations of isoflavones in soymilk during the fermentation 645 
period ± standard deviation. Means in the same column with different superscripts letters 646 
 are significantly different (P≤0.05). 647 
 648 
 Bacteria 
species 
Time/ 
h 
Sugars 
  Sucrose Glucose 
Daidzin Daidzein Equol Daidzin Daidzein Equol 
B. breve 12 
24 
36 
48 
 
10.22±0.02a 
8.34±0.02b 
6.45±0.03c 
5.58±0.03d 
7.54±0.02a 
8.61±0.02b 
6.37±0.02c 
5.94±0.03d 
2.40±0.01a 
2.84±0.01a 
3.59±0.01b 
4.11±0.02c 
10.54±0.02a 
9.61±0.02b 
8.97±0.02c 
8.14±0.03d 
6.40±0.01a 
6.84±0.01b 
5.59±0.01c 
3.81±0.02d 
3.22±0.02a 
3.34±0.02a 
3.45±0.03b 
3.58±0.03b 
B. longum 12 
24 
36 
48 
10.17±0.01a 
9.45±0.05b 
7.46±0.05b 
5.48±0.07b 
6.14±0.04a 
7.63±0.05b 
6.37±0.06c 
5.98±0.04d 
2.74±0.02a 
2.95±0.11a 
3.39±0.05b 
3.88±0.06b 
10.44±0.04a 
9.83±0.05b 
9.37±0.06b 
8.68±0.04c 
 
6.74±0.02a 
5.95±0.11b 
3.39±0.05c 
2.88±0.06d 
2.17±0.01a 
3.45±0.05b 
3.46±0.05b 
3.48±0.07b 
B. breve + B. 
longum 
12 
24 
36 
48 
7.26±0.025a                   
6.32±0.067b                        
5.10±0.017c                        
4.33±0.035d 
 
8.44±0.053a               
9.50±0.023b                        
6.78±0.043c                          
3.63±0.029d 
3.32±0.01a                
5.97±0.03b                      
6.61±0.03c                      
7.31±0.06d 
10.14±0.05a               
8.50±0.02b                      
7.78±0.04c                      
6.63±0.03d 
7.72±0.02a                
6.97±0.03b                        
5.61±0.03c                        
4.31±0.06d 
4.2±0.025a                   
5.32±0.07b                      
5.90±0.02c                    
6.33±0.04d 
 
26 
 
 649 
 650 
Table 5: Concentrations of isoflavones (mmol l-1) in soymilk supplemented with FOS inulin and fermented with single and co-651 
culture of B. breve and B. longum BB536 for 48 h 37⁰C. 652 
 653 
Values are Means of concentrations of isoflavones in soymilk during the fermentation period ± standard deviation. Means in the same 654 
column for particular species with different superscripts letters are significantly different (P≤0.05). 655 
 656 
 657 
 658 
 659 
Bacteria 
species 
Time 
(h) 
Prebiotics 
FOS Inulin 
Daidzin       Daidzein      Equol Daidzin     Daidzein  Equol 
B. breve 12 9.43±0.01a 7.77±0.01a 3.54±0.02a 7.62±0.02a 9.40±0.01a 3.76±0.06a 
24 7.36±0.01b 9.85±0.02b 3.61±0.02b 6.34±0.02b 10.84±0.01b 4.24±0.06b 
36 6.91±0.01c 10.84±0.02c 4.37±0.02c 4.45±0.03c 7.59±0.01c 5.06±0.06c 
48 5.97±0.01d 8.17±0.03d 4.94±0.03d 2.58±0.03d 4.11±0.02d 6.79±0.01d 
B. longum 12 9.39±0.01a 8.14±0.02a 2.14±0.04a 9.17±0.01a 7.74±0.02a 2.12±0.03a 
24 7.56±0.05b 8.95±0.11b 2.63±0.05b 8.45±0.05b 8.95±0.11b 3.46±0.02b 
36 6.03±0.05b 9.39±0.05c 3.37±0.06c 6.46±0.05b 6.39±0.05c 3.91±0.06c 
48 5.48±0.07b 7.88±0.06d 3.98±0.04d 4.48±0.07b 5.88±0.06d 4.38±0.10d 
B. breve 
+B. longum 
12 8.2±0.025a 10.32±0.02a 4.44±0.05a 6.2±0.025a         10.32±0.02a 6.82±0.02a 
24 6.32±0.07b 9.97±0.03b 5.50±0.02b 5.32±0.07b 9.97±0.03b 8.61±0.04b 
36 5.90±0.02c 6.61±0.03c 6.78±0.04c 3.90±0.02c 6.61±0.03c 9.27±0.04c 
48 4.33±0.04d 3.31±0.06d 8.63±0.03d 1.53±0.04d 2.31±0.05d 11.49±0.36d 
27 
 
 660 
Table 6: Concentration of equol (mmol l-1) in soymilk supplemented with different carbohydrates and fermented with single 661 
and co-culture of B. breve ATCC 15700 and B. longum BB536 for 48 h. 662 
Bacteria species Time/h SM+ Glucose SM+ Sucrose SM+ FOS SM+ Inulin 
B. breve 12 2.52±0.02a 1.40±0.01a 3.54±0.02a 3.76±0.06a 
24 3.34±0.02b 2.84±0.01b 3.61±0.02b 4.24±0.06b 
36 3.45±0.03b 3.59±0.01c 4.37±0.02c 5.06±0.06c 
48 3.58±0.03b 4.11±0.02d 4.94±0.03d 6.79±0.01d 
 
B. longum 
 
12 
 
2.17±0.01a 
 
2.74±0.02a 
 
2.14±0.04a 
 
2.12±0.03a 
24 3.45±0.05b 2.95±0.11b 2.63±0.05b 3.46±0.02b 
36 3.46±0.05b 3.39±0.05c 3.37±0.06c 3.91±0.06c 
48 3.48±0.07b 3.88±0.06d 3.98±0.04d 4.38±0.10d 
 
B. breve + B. longum 
 
12 
 
4.22±0.03a 
 
4.32±0.02a 
 
4.44±0.05a 
 
6.82±0.02a 
24 5.32±0.07b 5.97±0.03b 5.50±0.02b 8.61±0.04b 
36 5.90±0.02c 6.61±0.03c 6.78±0.04c 9.27±0.04c 
48 6.33±0.04d 7. 31±0.06d 8.63±0.03d 11.49±0.36d 
Values are Means of concentration of equol during the 48 h fermentation period ± standard deviation. Means in the same column for 663 
particular species with different superscripts letters are significantly different (P≤0.05). SM= Soymilk 664 
 665 
 666 
 667 
 668 
